Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Department of Ophthalmology Semmelweis University, Budapest, Hungary

In this page

How to contact the center

Affiliated

HCP Center

Semmelweis University Budapest is a leading institution of higher education in Hungary and the Central European region within the area of medicine and health sciences. Its main commitment is based on the integrity of education, research and healing, which make Semmelweis University an internationally renowned centre of knowledge. A truly international community, programmes are offered in three languages (Hungarian, English, German), and international students account for nearly a third of the around 11,000 students studying at the University’s six faculties.
Research, development, and innovation comprise an important part of the University’s three-fold mission. The Department of Ophthalmology is the legal successor of the first Hungarian Department of Ophthalmology, which was founded in 1804. It has been operating in its present location since 1908. The Department provides a wide coverage of services for most ophthalmic conditions, including general ophthalmology, vitreoretinal service (conservative and surgical retina), ophthalmic oncology, pediatric ophthalmology, orthoptics, strabology and an outpatient clinic for inherited retinal disorders.

Contact

Department of Ophthalmology Semmelweis University, Budapest, Hungary

Mária u. 39
1085 Budapest
Hungary

Team

Zoltán Zsolt Nagy

Hungary

Anterior Segment Rare Eye Diseases (WG4)
See more

Dr Ditta Zobor

Hungary

National Integration (TWG9), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Clinical trials

NCT03364153 - Active, Not recruiting

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Interventional
See the trial
voir la fiche
NCT04435366 - Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche

NCT04270747 - Completed

A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT04276558 - Recruiting, Active

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Interventional
See the trial
voir la fiche